Apoha Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 30-12-2024
- Paid Up Capital ₹ 0.10 M
as on 30-12-2024
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 0.50 M
as on 30-12-2024
- Revenue %
(FY 2022)
- Profit 12.70%
(FY 2022)
- Ebitda 33.49%
(FY 2022)
- Net Worth -8.56%
(FY 2022)
- Total Assets -2.73%
(FY 2022)
About Apoha Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹0.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Pranav Kariya, Megha Kariya, and Mehulkumar Radadiya serve as directors at the Company.
- CIN/LLPIN
U24230GJ2015PTC083262
- Company No.
083262
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 May 2015
- Date of AGM
12 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Apoha Pharmaceutical Private Limited offer?
Apoha Pharmaceutical Private Limited offers a wide range of products and services, including Ayurvedic & Herbal Extracts, Fruit Extracts, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Flavours & Aromatics, Sweetener.
Who are the key members and board of directors at Apoha Pharmaceutical?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pranav Kariya  | Director | 20-May-2015 | Current |
| Megha Kariya | Director | 08-Jun-2016 | Current |
| Mehulkumar Radadiya | Director | 07-Sep-2017 | Current |
Financial Performance of Apoha Pharmaceutical.
Apoha Pharmaceutical Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 12.7% increase in profit. The company's net worth dipped by a decrease of 8.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apoha Pharmaceutical?
In 2019, Apoha Pharmaceutical had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 07 Sep 2017 | ₹0.50 M | Satisfied |
How Many Employees Work at Apoha Pharmaceutical?
Unlock and access historical data on people associated with Apoha Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apoha Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apoha Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
